Purchase

Recombinant Human SCF protein (Myc & 6*His)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

Myc Tag, His Tag

Activity

not tested

Cat no : Eg0112


Product Information

Purity >90 %, SDS-PAGE
Endotoxin <1.0 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human SCF protein Glu26-Ala189 (Accession# P21583) with a Myc tag and a His tag at the C-terminus.
GeneID 4254
Accession P21583
PredictedSize 24.1 kDa
SDS-PAGE
Formulation Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Stem cell factor (SCF) is also named as mast cell growth factor (MGF), Kit ligand (Kitl), c-Kit ligand, steel factor and Kitlg. SCF is a pleiotropic cytokine (also as a dimeric molecule) that mediates regulatory effects on inflammation, tissue remodeling, and fibrosis through binding to and activating its receptor tyrosine kinase c-Kit. SCF is the ligand of c-Kit, a member of the RTKs family. Molecular activity of RTKs is a primary stimulus of cell motility, and expression of the SCF/c-Kit axis is associated with cell migration. SCF is a cytokine that synergizes the effects of Epo during erythropoiesis. Stem cell factor plays a well-described role in regulating the survival, proliferation, migration, and differentiation of hematopoietic progenitors, melanocytes, and germ cells. More recent studies have demonstrated SCF expression in dermal and intestinal epithelial cells, and increased SCF expression has been reported in the inflamed mucosa of individuals with IBD and colonitis.

References:

1. Williams, D E et al. Cell vol. 63,1 (1990): 167-74. 2. Lukacs, N W et al. Blood vol. 87,6 (1996): 2262-8. 3. Lennartsson, Johan, et al. Physiological reviews vol. 92,4 (2012): 1619-49. 4. Vazquez-Mellado, Maria J et al. Vitamins and hormones vol. 105 (2017): 273-296. 5. Garcia-Hernandez, Vicky et al. Inflammatory bowel diseases vol. 29,7 (2023): 1133-1144. 6. Carter, Eric L et al. The Journal of investigative dermatology vol. 128,7 (2008): 1861-3. 7. Schmitt, Mark et al. Cell reports vol. 24,9 (2018): 2312-2328.e7.